Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hvidovre University Hospital | OTHER |
| University of Copenhagen | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PURPOSE Physical exercise is beneficial for patients with ischemic heart disease and chronic heart failure, while little is known about the effect in atrial fibrillation (AF). The investigators studied the effect of physical exercise on cardiac output (CO), max. exercise capacity, biomarkers and quality of life (Qol) in patients with AF in a randomised study of physical exercise training three times weekly for twelve weeks.
HYPOTHESIS Exercise training improves cardiac output (CO), max. exercise capacity, biomarkers and quality of life (Qol) in patients with AF.
METHODS Assessment of exercise capacity, CO, Qol, body composition, six minute walk test and muscular strength was performed before and after 12 weeks.
Resting echocardiography was done at baseline. CO was measured using impedance cardiography at rest and during maximal exercise testing on an ergometer bicycle. Body composition, muscular strength and six minutes walking capacity were measured before and after the training period. Qol was evaluated by the use of the standardized validated questionnaires Short Form 36 (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLHF-Q).
Training consisted of aerobic exercise at 70 percent of max. capacity estimated by Borg-scale.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| No intervention | No Intervention | Observation only | |
| Exercise training group | Experimental | Group exercise training, three times weekly high-intensity |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| exercise training | Behavioral | group based exercise training |
|
| Measure | Description | Time Frame |
|---|---|---|
| cardiac output | participants will be followed for the duration of the intervention, an average of 12 weeks | participants will be followed for the duration of the intervention, an average of 12 weeks |
| Quality of life | participants will be followed for the duration of the intervention, an average of 12 weeks | participants will be followed for the duration of the intervention, an average of 12 weeks |
| exercise capacity | participants will be followed for the duration of the intervention, an average of 12 weeks | participants will be followed for the duration of the intervention, an average of 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| muscle strength | participants will be followed for the duration of the intervention, an average of 12 weeks | participants will be followed for the duration of the intervention, an average of 12 weeks |
| biomarkers ANB, BNP |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Philip S Osbak, MD | Hvidovre University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hvidovre Hospital | Copenhagen | Hvidovre | 2650 | Denmark |
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
participants will be followed for the duration of the intervention, an average of 12 weeks
| participants will be followed for the duration of the intervention, an average of 12 weeks |
| Body composition DEXA-scan | participants will be followed for the duration of the intervention, an average of 12 weeks | participants will be followed for the duration of the intervention, an average of 12 weeks |
| D013568 |
| Pathological Conditions, Signs and Symptoms |